Skip to main content

Cocrystal Pharma, Inc.

corporate_fare Company Profile

Cocrystal Pharma, Inc.

COCP·NASDAQ·Life Sciences·CIK 0001412486

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on discovering and developing new antiviral treatments for serious and/or chronic viral diseases. The company uses unique structure-based technologies and expertise to create antiviral drugs. These technologies aim to produce small molecule therapeutics that are safe, effective, and easy to administer. Cocrystal has identified promising antiviral compounds at discovery, preclinical, and clinical stages. These compounds target unmet medical needs caused by RNA viruses, including influenza virus, norovirus, coronaviruses (such as SARS-CoV-2 & MERS-CoV), respiratory virus infections, and hepatitis C virus ("HCV") infections. The company operates as a single business entity. Cocrystal's technology involves developing small molecule antiviral therapeutics that inhibit the essential replication function of RNA viruses. The company's goals include treating and preventing influenza virus, norovirus, and coronavirus infections by discovering and developing direct-acting antiviral drug candidates that target required steps in the viral replication process. To achieve this, Cocrystal uses a proprietary platform that includes computational chemistry, medicinal chemistry, X-ray crystallography, and extensive know-how. The company determines the structures of cocrystals containing inhibitors bound to the viral enzyme or protein to guide its structure-based drug design. It also uses advanced computational methods to screen and design product candidates, utilizing proprietary high-resolution cocrystal structural information. In designing candidates, Cocrystal aims to anticipate and prevent potential viral mutations that could lead to resistance. The company seeks to develop drugs that are effective against both the virus and its possible mutants, with reduced off-target interactions to minimize undesirable clinical side effects. This approach requires extensive knowledge of viruses, drug targets, structural biology, pharmacology, virology, and enzymology.

Cocrystal Pharma, Inc. (NASDAQ:COCP) is a publicly traded company in the Life Sciences sector. Wiseek monitors COCP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cocrystal Pharma Appoints Biopharma Veteran James Sapirstein as New CEO
  • Cocrystal Pharma Appoints Biopharma Veteran James Sapirstein as New CEO
  • Cocrystal Pharma Cuts Co-CEO Salaries by 40% Amidst Going Concern Warning; Grants New Equity Options
  • Cocrystal Pharma Discovers Pan-Viral Inhibitors for Hantavirus, Bunyavirus, and Influenza
  • Cocrystal Pharma Discovers Pan-Viral Inhibitors for Hantavirus, Bunyavirus, and Influenza

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$8.83M
Diluted EPS
-$0.78
Op. Cash Flow
-$8.19M
Free Cash Flow
-$8.2M
Operating Income
-$9.02M
Cash & Equivalents
$7.03M
Debt / Equity
0.00×
Shares Outstanding
13.78M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-013838
Browse all tickers starting with C →
$1 +0.01% today
52-week range · as of 2026-06-09 $0.8588 – $2.67
Market cap
$13.72M
Volume
80.6K (0.6× avg)
3-mo avg 126.3K
Live data · 2026-06-14 06:24 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COCP - Latest Insights

COCP
Jun 09, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.990
Real-time Price: $1.00 info
Change: +$0.0108 (+1%) info
Market Cap: $13.717M info
COCP
Jun 03, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.04
Real-time Price: $1.00 info
Change: -$0.0392 (-4%) info
Market Cap: $13.717M info
COCP
May 27, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.12
Real-time Price: $1.00 info
Change: -$0.1192 (-11%) info
Market Cap: $13.717M info
COCP
May 26, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.00 info
Change: -$0.1892 (-16%) info
Market Cap: $13.717M info
COCP
May 26, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.00 info
Change: -$0.2242 (-18%) info
Market Cap: $13.717M info
COCP
May 16, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.26
Real-time Price: $1.00 info
Change: -$0.2592 (-21%) info
Market Cap: $13.717M info
COCP
May 15, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.25
Real-time Price: $1.00 info
Change: -$0.2492 (-20%) info
Market Cap: $13.717M info
COCP
May 15, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $1.00 info
Change: -$0.2492 (-20%) info
Market Cap: $13.717M info
COCP
Apr 30, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $1.00 info
Change: -$0.4092 (-29%) info
Market Cap: $13.717M info
COCP
Apr 23, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $1.00 info
Change: -$0.3892 (-28%) info
Market Cap: $13.717M info
COCP
Apr 02, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $1.00 info
Change: -$0.2876 (-22%) info
Market Cap: $13.717M info
COCP
Apr 02, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.00 info
Change: -$0.1991 (-17%) info
Market Cap: $13.717M info
COCP
Mar 31, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.9901
Real-time Price: $1.00 info
Change: +$0.0107 (+1%) info
Market Cap: $13.717M info
COCP
Mar 31, 2026, 8:30 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.9901
Real-time Price: $1.00 info
Change: +$0.0107 (+1%) info
Market Cap: $13.717M info
COCP
Mar 31, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9901
Real-time Price: $1.00 info
Change: +$0.0107 (+1%) info
Market Cap: $13.717M info
COCP
Mar 13, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.00 info
Change: -$0.0292 (-3%) info
Market Cap: $13.717M info
COCP
Mar 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.00 info
Change: -$0.0592 (-6%) info
Market Cap: $13.717M info
COCP
Feb 19, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9799
Real-time Price: $1.00 info
Change: +$0.0209 (+2%) info
Market Cap: $13.717M info